Rights and permissions
About this article
Cite this article
Ritonavir-based HAART “may not be optimal” in infants. Inpharma Wkly. 1509, 19 (2005). https://doi.org/10.2165/00128413-200515090-00044
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200515090-00044